In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Operating Activities: | | | | | | | | |
Net income/(loss) | | | 1.6 | -4.9 | -16.0 | -18.6 | -38.9 | -45.8 |
Adjustments to reconcile net income (loss) to cash used in operating activities: | | | | | | | | |
Depreciation and amortization | | | 0.2 | 0.2 | 0.4 | 1.2 | 3.6 | 5.6 |
Share-based compensation | | | | 0.0 | 0.0 | 0.1 | 0.9 | 0.9 |
Accretion of debt discount | | | 1.4 | 4.7 | 5.2 | 4.4 | 6.2 | 24.0 |
Changes in operating assets and liabilities: | | | | | | | | |
Accounts receivable | | | 0.0 | 0.2 | -0.2 | 0.6 | 1.3 | 0.7 |
Inventories | | | 0.0 | 0.1 | 0.4 | 1.2 | 1.7 | -1.8 |
Prepaid expenses and other current assets | 0.7 | 0.3 | -0.5 | 0.1 | 0.4 | 0.4 | 0.4 | 0.2 |
Accounts payable | | | -0.3 | -0.3 | 1.0 | 0.4 | 1.5 | 2.1 |
Related party payable | | | -0.2 | 0.2 | 0.1 | 0.0 | | |
Accrued interest | | | 2.0 | 4.0 | 1.1 | 0.8 | 0.9 | 1.4 |
Accrued expenses | | | 0.4 | 0.1 | 1.1 | 0.0 | -0.5 | -1.2 |
Net cash used in operating activities | -10.5 | -9.4 | -2.9 | -2.7 | -4.0 | -12.6 | -16.9 | -22.1 |
|
Investing Activities: | | | | | | | | |
Contributions to equity method investment | 0.1 | 0.0 | | | | | | |
Net cash used in investing activities | -0.3 | -0.3 | 0.3 | 0.8 | 0.0 | 0.1 | -0.2 | -0.2 |
|
Financing Activities: | | | | | | | | |
Payment of convertible notes | | | | | | | | -1.0 |
Net cash used in financing activities | 16.3 | 15.5 | 2.8 | 1.9 | 3.9 | 12.5 | 16.8 | 19.3 |
|
Non-Cash Transactions: | | | | | | | | |
Purchase of equipment not yet paid at end of period | 0.2 | | | 0.2 | 0.1 | 0.4 | | |
Supplemental disclosure of cash flow information: | | | | | | | | |
Interest | | | | 0.0 | 0.2 | 1.2 | 0.4 | 0.5 |